The in vitro preconditioning of myoblasts to enhance subsequent survival in an in vivo tissue engineering chamber model

Biomaterials

Volumn 33, Issue 15, 2012, Pages 3868-3879

  Tilkorn, Daniel J ^b   Davies, E Michele ^c   Keramidaris, Effie ^a   Dingle, Aaron M ^a   Gerrand, Yi Wen ^a   Taylor, Caroline J ^a   Han, Xiao Lian ^a   Palmer, Jason A ^a   Penington, Anthony J ^a   Mitchell, Christina A ^c   Morrison, Wayne A ^a   Dusting, Gregory J ^a   Mitchell, Geraldine M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Cell preconditioning; Implantation in an in vivo tissue engineering chamber; In vitro test of cell survival; Morphometric assessment of cell survival

Indexed keywords

CELL LOSS; CHAMBER MODEL; IN VITRO TEST OF CELL SURVIVAL; IN-CONTROL; IN-VITRO; IN-VIVO; MORPHOMETRIC ASSESSMENT OF CELL SURVIVAL; MYOBLASTS; NITRIC OXIDE DONOR; SIGNALING PATHWAYS; THERAPEUTIC BENEFITS; THREONINE KINASE; TRANSPLANTED CELLS;

ACTIVATION ANALYSIS; AMINO ACIDS; CELLS; DRUG PRODUCTS; NITRIC OXIDE; TISSUE ENGINEERING;

CYTOLOGY;

1 [N (2 AMINOETHYL) N (2 AMINOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LOSS; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; HEAT; HYPOXIA; IMMUNOBLOTTING; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MORPHOMETRICS; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; CELL COUNT; CELL HYPOXIA; CELL LINE; CELL SIZE; CELL SURVIVAL; DESMIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; MODELS, BIOLOGICAL; MYOBLASTS; NITROSO COMPOUNDS; PROSTHESIS IMPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84858288915     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.006     Document Type: Article

References (32)

1. Hirschi K.K., Skalak T.C., Peirce S.M., Little C.D. Vascular assembly in natural and engineered tissues. Ann N Y Acad Sci 2002, 961:223-242.
2. Ishaug S.L., Crane G.M., Miller M.J., Yasko A.W., Yaszemski M.J., Mikos A.G. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997, 36:17-28.
3. Yang S., Leong K.F., Du Z., Chua C.K. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 2001, 7:679-689.
4. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant 1995, 4:415-436.
5. Tilkorn D., Bedogni A., Keramidaris E., Han X., Palmer J., Dingle A.M., et al. Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation /prevascularization tissue engineering model. Tiss Eng Part A 2010, 16:165-718.
6. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
7. Murry C.E., Richard V.J., Jennings R.B., Reimer K.A. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol Heart Circ Physiol 1991, 260:H796-H804.
8. Bolli R., Li Q.H., Tang X.L., Guo Y., Xuan Y.T., Rokosh G.D., et al. The late phase of preconditioning and its natural clinical application-gene therapy. Heart Fail Rev 2007, 12:189-199.
9. Zahir K.S., Syed S.A., Zink J.R., Restifo R.J., Thomson J.G. Ischemic preconditioning improves the survival of skin and myocutaneous flaps in a rat model. Plast Reconstr Surg 1998, 102:140-150.
10. Pang C.Y., Yang R.Z., Zhong A., Xu N., Boyd B., Forrest C.R. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 1995, 29:782-788.
11. Ishida T.Y.K., Gute D.C., Korthuis R.J. Mechanisms of ischemic preconditioning. Shock 1997, 9:86-94.
12. Bonventre J.V. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002, 11:43-48.
13. Suzuki K., Smolenski R.T., Jayakumar J., Murtuza B., Brand N.J., Yacoub M.H. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circ 2000, 102(19 Suppl. 3):III216-III221.
14. Niagara M.I., Kh H., Jiang S., Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007, 100:545-555.
15. Hu X., Yu S.P., Fraser J.L., Lu Z., Ogl M.E., Wang J., et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008, 135:799-808.
16. Pasha Z., Wang Y., Sheikh R., Zhang D., Zhao T., Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008, 77:134-142.
17. Cronin K.J., Messina A., Knight K.R., Cooper-White J.J., Stevens G.W., Penington A.J., et al. New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast Reconstr Surg 2004, 113:260-269.
18. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970, 26:57-60.
19. Rophael J.A., Craft R.O., Palmer J.A., Thomas G.P.L., Hussey A.J., Morrison W.A., et al. Angiogenic growth factor synergism in a murine tissue-engineering model of angiogenesis and adipogenesis. Am J Path 2007, 171:2048-2057.
20. Howard C.V., Reed M.G. Unbiased stereology 2005, BIOS Scientific Publishers, Taylor & Francis Group, Oxford.
21. Lokmic Z., Stillaert F., Morrison W.A., Thompson E.W., Mitchell G.M. An arterio-venous loop in a protected space generates a permanent, highly vascular, tissue engineered construct. FASEB J 2007, 21:511-522.
22. Tejedo J.R., Cahuana G.M., Ramírez R., Esbert M., Jiménez J., Sobrino F., et al. Nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1. Endocrinology 2004, 145:2319-2327.
23. Cahuana G.M., Tejedo J.R., Hmadcha A., Ramírez R., Cuesta A.L., Soria B., et al. Nitric oxide mediates the survival action of IGF-1 and insulin in pancreatic beta cells. Cell Signal 2008, 20:301-310.
24. Liao Y., Hung M.C. Physiological regulation of Akt activity and stability. Am J Transl Res 2010, 2:19-42.
25. Lee S.M., Lee C.T., Kim Y.W., Han S.K., Shim Y.S., Yoo C.G. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett 2006, 242:231-238.
26. Chen E.Y., Mazure N.M., Cooper J.A., Giaccia A.J. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res 2001, 61:2429-2433.
27. Alvarez-Tejado M., Naranjo-Suarez S., Jiménez C., Carrera A.C., Landázuri M.O., del Peso L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem 2001, 276:22368-22374.
28. Beitner-Johnson D., Rust R.T., Hsieh T.C., Millhorn D.E. Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. Cell Signal 2001, 13:23-27.
29. Chen J.X., Meyrick B. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab Invest 2004, 84:182-190.
30. Tzatsos A., Tsichlis P.N. Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J Biol Chem 2007, 282:18069-18082.
31. Ren H., Accili D., Duan C. Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways. Proc Nat Acad Sci 2010, 107:5857-5862.
32. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 2001, 33:1897-1918.